Results 41 to 50 of about 23,898 (157)

Combined oral contraception and treatment of new coronavirus infection (COVID-19): drug interaction issues

open access: yesФармакокинетика и Фармакодинамика, 2021
Combined oral contraception and treatment of new coronavirus infection (COVID-19): issues of drug interaction This article examines the interaction of combined oral contraceptives with drugs recommended in the treatment of new coronavirus infection ...
O. A. Limanova   +2 more
doaj   +1 more source

New trends in antithrombotic therapy in vascular neurology

open access: yes, 2021
In recent years, for the first time in developed economies and high-income countries, a reduction in the incidence of stroke has been achieved. The trend towards a decrease in cardiovascular morbidity in economically developed countries of the world ...
E. A. Shirokov, Е.А. Широков
core   +1 more source

Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

open access: yesBleeding, Thrombosis and Vascular Biology, 2022
For almost 90 years, the discovery and development of anticoagulant drugs have focused on maximizing their antithrombotic efficacy while minimizing the risk of bleeding, in addition to providing manageable compounds with predictable and/or monitorable ...
Marco P. Donadini, Walter Ageno
doaj   +1 more source

Outcomes According to Antithrombotic and Admission Major Neurologic Dysfunction Status.

open access: yes, 2014
AT, antithrombotic; (−), negative; (+), positive; AMND, Admission Major Neurologic Dysfunction; ICH, intracranial hemorrhage; AIS, Abbreviated Injury Scale score.Outcomes According to Antithrombotic and Admission Major Neurologic Dysfunction Status.
David J. Gemmel (639333)   +5 more
core   +1 more source

Comparison of clinical outcomes according to antithrombotic therapy.

open access: yes, 2022
Comparison of clinical outcomes according to antithrombotic therapy.
Eue-Keun Choi (3536411)   +10 more
core   +1 more source

Antithrombotic Therapy [PDF]

open access: yesCurrent Molecular Medicine, 2006
Coronary heart disease is the leading cause of death in the US and the industrialized world. Ever since DeWood in 1980 demonstrated that a thrombus was the primary event leading to acute myocardial infarction and that they may subsequently lyse, the mainstay of therapy for the past 25 years has been antithrombotic therapy aimed at coronary thrombosis ...
openaire   +2 more sources

Hypolipidemic and Antithrombotic Effect of 6′-O-Caffeoylarbutin from Vaccinium dunalianum Based on Zebrafish Model, Network Pharmacology, and Molecular Docking

open access: yesMolecules
Vaccinium dunalianum leaf buds make one of the most commonly used herbal teas of the Yi people in China, which is used to treat articular rheumatism, relax tendons, and stimulates blood circulation in the body. In addition, 6′-O-caffeoylarbutin (CA) is a
Boxiao Wu   +6 more
doaj   +1 more source

Efficacy and Safety of Direct Oral Anticoagulants in Elderly Patients With Atrial Fibrillation: A Network Meta-Analysis

open access: yesFrontiers in Medicine, 2020
Background: Direct oral anticoagulants (DOACs) have been widely used in patients with atrial fibrillation (AF) for antithrombotic prophylaxis, which were shown to have a favorable risk–benefit profile.
Kaisheng Deng   +5 more
doaj   +1 more source

Antiplatelet and Antithrombotic Effects of Isaridin E Isolated from the Marine-Derived Fungus via Downregulating the PI3K/Akt Signaling Pathway

open access: yesMarine Drugs, 2021
Isaridin E, a cyclodepsipeptide isolated from the marine-derived fungus Amphichorda felina (syn. Beauveria felina) SYSU-MS7908, has been demonstrated to possess anti-inflammatory and insecticidal activities.
Ni Pan   +11 more
doaj   +1 more source

Anticoagulant and Fibrinolytic Properties of Two Heparinoid Compounds Prepared from Shrimp Waste

open access: yesFoods, 2022
Heparinoid, a type of compound that has structures similar to heparin, has been found in marine organisms such as shrimp head. This shrimp waste products were used to prepare, characterize, and evaluate the antithrombotic effect of heparinoid.
Jing Chen   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy